Note that these results probably apply to Mounjaro/Zepbound as well, because they are the most effective GLP1s on the market right now:

https://glp1.guide/content/semaglutide-vs-tirzepatide-clinic...

My bet is on the reduction in inflammation -- it's a notoriously beneficial positive side effect of GLP1 Receptor Agonists, along with the obvious reduction in weight or HbA1c.